Image Map-LE-like

Section 5, Chapter2 - Image Map (tier 2)

The conventions are the same as for all the preceding sections: “S” = section, “C” = chapter of the section, “VA” = visual aid, and “P” = pictorial. Items identified with the suffix “-X” at level 2 are parent textual chapters for one or a group of pictorial chapters. In this approach, pictorials are accessible (with the sequence, or NEXT button) in groups, with each group having relevance to a particular textual page at tier 2. A label in the MASTERBORDER to the left with only an “S-C-” identifies a textual chapter. If it is additionally identified by an “-X”, then the textual chapter is a parent chapter for one or a group of pictorials. If a underlined label in the list below (in the IMAGE MAP and before the SECTION MAP) is identified by an “S-C-” and a “VA-” or a “P-,” then a click on such a label will take the reader to a pictorial at the third tier. The SECTION MAP is descriptive; each designation for a section is accompanied by a brief description of the general topic.

S5-IMAGE MAP

VISUAL AIDS

S5C6VA1-1: listing of examples of cell-poor lichenoid disorders; S5C6VA1-2: diagramatic representation of epidermal target-sites; S5C6VA1-3: the role of histiocytes in the mediation of tissue damage in lupus erythematosus (LE); S5C6VA1-4: functioning units of the epidermis (pemphigus foliaceus as an example);

S5C19VA2-1: connective tissue activation (drawing);

S5C19VA2-2: immunologic barrier (drawing);

S5C19VA2-3: uncommon variants of mucinosis (listing);

S5C19VA2-4: pigmented lichenoid reactions (listing)

S5C19VA2-5: cutaneous domains (collagen-vascular diseases - drawing)

PHOTOMICROGRAPHS

S5C7P1-1: graft vs host reaction as a model for cell-poor lichenoid reaction;

S5C7P1-2-4: systemic lupus erythematosus; S1C7P1-5 & 6: subacute lupus erythematosus;

S5C8P2-1-3: dermal-epidermal interface of lupus erythematosus;

S5C9P3-1-7: interface reactions (LE);

S5C9aP3a-1-2: interface reactions (subacute LE)

S5C10P4-1-5: discoid LE;

S5C10P4-6: LE-LP overlap syndrome;

S5C11P5-1-3: basement membrane hyalinosis (LE);

S5C11P5-4: hypertrophic LE;

S5C12P6-1-3: atrophic, sclerosing and senescent patterns (LE);

S5C12P6-4: senescent LE;

S5C12P6-5-7: LE mucinosis

S5C12aP6a-1-6: LS&A, basement membrane changes

S5C13P7-1-2: LE-LP overlap syndrome;

S5C13P7-3-5: neonatal LE;

S5C13P7-6: scarring alopecia (LE);

S5C13P7-7-10: erythema multiforme in the setting of lupus erythematosus.

S5C14P8-1-5: abnormalities near the dermal-epidermal interface (LE);

S5C15P9-1-6: connective changes (LE);

S5C16P10-1: senescent changes with follicular ectasia (LE);

S5C16P10-2: interface changes (LE);

S5C16P10-3-6: LE tumidus (mucinosis);

S5C17P11-1-4: LE tumidus (mucinosis);

S5C18P12-1-4: LE mucinosis with hyperplasia of histiocytes

S5C18P12-5-8: graft vs host reaction;

S5C18aP12a-1-5: graft vs host reaction;

S5C18bP12b-1-7: graft vs host reaction (LE-like);

S5C20P13-1-5:  lupus profundus;

S5C20aP13a-1-7: dermatomyositis;

S5C21P14-1-6: erythema dyschromicum perstans;

S5C21P14-7: pruritic pigmented patches (macular amyloidosis ab amyloid;

S5C22P15-1-3: erythema dyschromicum perstans:

S5C23P16-1: miscellaneous lichens:

S5C24P17-1-6: lymphocytic infiltrates of dermis

S5C25P18-1-5: lymphocytic infiltrate of Jessner;

S5C26P19-1-6: erythema annulare centrifigum;

S5C27P20-1-5: lymphocytic infiltrates of dermis

S5C28P21-1-2: lymphocytic infiltrates of dermis;

S5C28P21-3-6: lichen amyloidosis

S5C28P21-7: rosacea

S5C29P22-1: lymphocytic infiltrate, mucinosis;

S5C29P22-2-6: Degos disease;

S5-SECTION MAP

Section 1: inflammation, general aspects;

Section 2: spongiotic and psoriasiform disorders;

Section 3: lichen planus-like disorders;

Section 4: lichenoid disorders, erythema multiforme-like and pityriasic;

Section 5: lichenoid disorders, lupus erythematosus-like;

Section 6: vesiculo-bullous disorders (1);

Section 7: vesiculo-bullous disorders (2);

Section 8: vasculitides;

Section 9: collagenoses;

Section 10: panniculitides;

Section 11: infectious disorders;

Section 12: granulomatous disorders;

Section 13: borderline disorders;

Section 14: clinical photographs;

Section 15: borderline disorders (2);

Section 16: Site Diagram.

 

Next Page

Previous Page

Up a Page

BuiltWithNOF

last two (green) items along bottom row to right are web sites; all others in cluster provide access to SECTIONS of this SITE.